Chemed Corporation (NYSE: CHE) reported Q3 EPS of $5.06, $0.54 better than the analyst estimate of $4.52. Revenue for the quarter came in at $539 million versus the consensus estimate of $531.87 million.

GUIDANCE:

Chemed Corporation sees FY2021 EPS of $17.00-$17.50, versus the consensus of $17.91.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.